IP Library Assignment 027307/0482
Patent Assignment
Reel/Frame 027307/0482

Merger

Recorded: 2011-12-01 Pages: 20
Assignor
N.V. ORGANON
Executed: 2011-10-31
Assignee
MSD OSS B.V.
KLOOSTERSTRAAT 6, 5349 AB OSS, NETHERLANDS
Covered Properties (203)
Progestogen-Only Contraceptive
Patent: 5,461,041 →
Application: 08/183,644 →
Low Steroid Dose Dry Pharmaceutical Preparation
Patent: 5,382,434 →
Application: 08/216,236 →
Pharmacetical Granulate
Patent: 5,395,627 →
Application: 07/941,026 →
Pharmaceutical Granulate
Patent: 5,527,543 →
Application: 08/366,348 →
Method for Preparing 213 Bi for Therapeutic Use
Patent: 5,641,471 →
Application: 08/527,296 →
Lyospheres Comprising Gonadotropin
Patent: 5,656,597 →
Application: 08/454,333 →
Spike Retainer System
Patent: 5,472,434 →
Application: 08/061,031 →
Antiglucocorticoid Steroids for the Treatment of Anxiety Disorders
Patent: 5,741,787 →
Application: 08/581,631 →
Sublingual or Buccal Pharmaceutical Composition
Patent: 5,763,476 →
Application: 08/693,064 →
Dna Encoding
Patent: 7,060,490 →
Application: 08/826,361 →
Estrogen Receptor Beta
Patent: 6,680,368 →
Application: 09/608,088 →
Method for identifying Ligand of estrogen receptor beta
Patent: 6,713,270 →
Application: 09/711,288 →
Isolated Human Bmp-4 Promoter Region
Patent: 6,159,696 →
Application: 09/308,406 →
Method of Preparing a Monoclonal Antibody
Patent: 6,020,170 →
Application: 08/985,898 →
Method of Preparing a Monoclonal Antibody, a Pharmaceutical Composition and a Diagnastic Reagent
Patent: 6,392,020 →
Application: 09/405,745 →
Liquid Gonadotropin Containing Formulations
Patent: 5,929,028 →
Application: 09/006,812 →
Derivatives of azetidine and pyrrolidine
Patent: 6,281,243 →
Application: 09/622,705 →
Compounds of Azetidine and Pyrroline
Patent: 6,403,573 →
Application: 09/870,032 →
Publication: US US20020040016A1
Steroid compounds having contraceptive and anti-osteoporosis activity
Patent: 6,313,180 →
Application: 09/538,783 →
Steroid Compounds Having Contraceptive and Anti-Osteoporsis Activity
Patent: 6,077,873 →
Application: 09/026,348 →
Therapeutic Combinations of Mirtazapine and Antipsychotic Agents, for the Treatment or Prophylaxis of Psychotic Disorders
Patent: 6,150,353 →
Application: 09/380,723 →
Drug Delivery System for Two or More Active Substances
Patent: 5,989,581 →
Application: 09/056,700 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent: 6,444,672 →
Application: 09/550,954 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent: 6,797,710 →
Application: 10/178,441 →
Publication: US US20030130270A1
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent: 6,432,955 →
Application: 09/679,232 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent: 6,194,409 →
Application: 09/403,327 →
Gonadotropin Releasing Hormone Antagonist
Patent: 6,653,286 →
Application: 09/446,324 →
Tetrahydroimidazo[2,1-A]Isoquinoline Derivatives
Patent: 5,994,366 →
Application: 09/104,563 →
Process for the Production of Heparin
Patent: 6,232,093 →
Application: 09/462,223 →
Solid Phase Supports
Patent: 6,486,354 →
Application: 09/485,613 →
Benzylamine Derivatives Which Are Useful in Treating Psychiatric Disorders
Patent: 6,080,773 →
Application: 08/950,359 →
Benzylamine Derivatives Which Are Useful in Treating Psychiatric Disorders
Patent: 6,313,139 →
Application: 09/359,284 →
Vinyl Sulphone Modified Polymer
Patent: 7,183,367 →
Application: 10/799,912 →
Publication: US US20040186256A1
Antithrombotic Compounds
Patent: 6,486,129 →
Application: 09/719,841 →
Aminomethylcarboxylic Acid Derivatives
Patent: 6,410,592 →
Application: 09/744,520 →
Folliculogenesis
Patent: 6,660,717 →
Application: 09/856,995 →
Drug of Improving Optic Nerve Head Circulation Disorder
Patent: 6,387,910 →
Application: 09/601,231 →
Process for the Microbial Conversion of Phytosterols to Androstenedione and Androstadienedione
Patent: 6,071,714 →
Application: 09/048,432 →
14-Beta,17-Alpha-Hydroxymethylandrostane Derivatives as Androgens
Patent: 6,881,728 →
Application: 09/890,845 →
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Patent: 6,569,863 →
Application: 09/937,416 →
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Patent: 6,841,553 →
Application: 10/411,960 →
Publication: US US20030212081A1
Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
Patent: 7,265,099 →
Application: 10/049,393 →
Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
Application: 12/628,640 →
Publication: US US20100075938A1
Spiro(2H-1-Benzopyran-2,4-Piperidine)Derivates as Glycine Transport Inhibitors
Patent: 6,645,973 →
Application: 10/130,557 →
Spiro(2H-1BENZOPYRAN-2,4'-Piperidine) Derivates as Glycine Transport Inhibitors
Patent: 7,507,824 →
Application: 10/637,681 →
Publication: US US20040029904A1
6-Mercapto-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
Patent: 6,949,527 →
Application: 10/603,355 →
Publication: US US20040029833A1
6-Mercapto-Cyclodextrin Derivatives:Reversal Agents for Drug-Induced Neuromuscular Block
Patent: 6,670,340 →
Application: 10/148,307 →
Antithrombotic Compound
Patent: 6,875,755 →
Application: 10/148,868 →
Publication: US US20030114361A1
Use of Mirtazapine for the Treatment of Sleep Disorders
Patent: 6,933,293 →
Application: 10/203,232 →
Publication: US US20030022888A1
Chroman Derivatives as Estrogenic Compounds
Patent: 7,214,706 →
Application: 10/220,509 →
Publication: US US20030069303A1
Chroman Derivatives as Estrogenic Compounds
Patent: 7,531,571 →
Application: 11/328,760 →
Publication: US US20060160889A1
Chroman Derivatives as Estrogenic Compounds
Patent: 7,846,966 →
Application: 12/437,883 →
Publication: US US20090221695A1
Electronic Alarm Timer for Use with a Medical Regimen
Patent: 7,369,463 →
Application: 10/203,196 →
Full Length Human HCN1IH Channel Subunit and Variants
Patent: 7,329,510 →
Application: 10/296,270 →
Publication: US US20030180753A1
16,17-Carbocyclic Condensed Steroid Compounds Having Selective Estrogenic Activity
Patent: 7,868,193 →
Application: 10/297,706 →
Publication: US US20040102426A1
16, 17-Carbocyclic Condensed Steroid Compounds Having Slective Estrogenic Activity
Application: 13/112,184 →
Publication: US US20110224183A1
Bicyclic Heteroaromatic Compounds
Patent: 7,229,990 →
Application: 10/381,248 →
Publication: US US20030225113A1
Bicyclic Heteroaromatic Compounds
Patent: 7,618,963 →
Application: 11/788,886 →
Publication: US US20070197527A1
14 Beta, 16, 17-Methylene Steroids as Novel Androgens
Patent: 6,949,531 →
Application: 10/450,278 →
Publication: US US20040030165A1
2-Alkylated-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
Patent: 7,026,304 →
Application: 10/468,072 →
Publication: US US20040106575A1
THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
Patent: 7,317,006 →
Application: 10/488,482 →
Publication: US US20040180873A1
Benzoxazepines Derivatives and Their Use as Ampa Receptor Stimulators
Patent: 7,307,073 →
Application: 10/480,623 →
Publication: US US20040171605A1
Benzoxapzepine Derivatives and Their Use as Ampa Receptor Stimulators
Patent: 7,504,390 →
Application: 11/924,451 →
Publication: US US20080139529A1
(Pyrido/Thieno) - [F] - Oxazepine-5-One Derivatives
Patent: 7,345,036 →
Application: 10/480,569 →
Publication: US US20040220175A1
(Pyrido/Thieno)-[F]-Oxazepine-5-One Derivatives
Patent: 7,566,778 →
Application: 12/024,597 →
Publication: US US20080262221A1
(Pyrido/Thieno)-[F]-Oxazepine-5-One Derivatives
Patent: 8,034,804 →
Application: 12/389,968 →
Publication: US US20090163473A1
Tetrahydroquinoline Derivatives
Patent: 8,058,441 →
Application: 10/482,707 →
Publication: US US20040236109A1
Process for the Preparation of Peptides
Patent: 6,864,357 →
Application: 10/199,785 →
Publication: US US20030018163A1
Process for Rapid Solution Synthesis of Peptides
Patent: 7,435,791 →
Application: 10/693,802 →
Publication: US US20040087768A1
C-14 Oxidation of Morphine Derivatives
Patent: 7,435,817 →
Application: 10/487,884 →
Publication: US US20050038250A1
Glycine-Substituted Thieno[2,3-D]Pyrimidines with Combined Lh and Fsh Agonistic Activity
Patent: 7,375,109 →
Application: 10/488,483 →
Publication: US US20040180907A1
17ALPHA-Hydroxy-14BETA-Steroids with Hormonal Effect
Patent: 7,169,769 →
Application: 10/489,456 →
Publication: US US20040259849A1
Tetrahydrobenzfluorene Derivatives
Patent: 7,655,653 →
Application: 11/924,507 →
Publication: US US20080058361A1
Tetrahydrobenzfluorene Derivatives
Patent: 7,304,155 →
Application: 10/499,956 →
Publication: US US20050119264A1
Process for the preparation of 7alpha-methylsteroids
Application: 10/502,259 →
Publication: US US20050090476A1
1-Arylsulfonyl-3-Substituted Indole and Indoline Derivatives Useful in the Treatment of Central Nervous System Disorders
Patent: 7,838,518 →
Application: 10/504,556 →
Publication: US US20050154023A1
Substituted 10-Aryl-11H-Benzo[B]Fluourenes and 7-Aryl-5, 6-Dihydro-Benzo[a]Anthracenes for Selective Effects on Estrogen Receptors
Patent: 7,335,659 →
Application: 10/505,631 →
Publication: US US20050159405A1
Indoles Useful in the Treatment of Androgen-Receptor Related Diseases
Patent: 7,795,280 →
Application: 10/534,945 →
Publication: US US20060128722A1
Non-Steroidal Androgens Compounds
Patent: 8,124,647 →
Application: 12/875,295 →
Publication: US US20110065768A1
Non-Steroidal Progesterone Receptor Modulators
Patent: 7,737,136 →
Application: 10/510,275 →
Publication: US US20050171087A1
Etonogestrel Esters
Patent: 7,323,454 →
Application: 10/516,402 →
Publication: US US20050222113A1
1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives
Patent: 7,304,064 →
Application: 10/518,279 →
Publication: US US20050250760A1
Tetrahydorquinoline Derivatives and Their Use as Fsh Receptor Modulators
Patent: 7,674,909 →
Application: 10/540,335 →
Publication: US US20060167047A1
Tetrahydroquinoline Derivatives
Patent: 7,858,794 →
Application: 10/540,336 →
Publication: US US20060142334A1
Method for protein isolation in anoxic conditions
Application: 10/543,524 →
Publication: US US20060128942A1
Drug Delivery System
Patent: 8,333,983 →
Application: 10/558,040 →
Publication: US US20060280771A1
Method for the Preparation of Enantiomerically Pure Mirtazapine
Patent: 8,058,436 →
Application: 10/564,193 →
Publication: US US20060229300A1
Tricyclic 1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives as Cannabinoid CB1 Receptor Agonists
Patent: 7,772,227 →
Application: 10/583,013 →
Publication: US US20070088025A1
Antisolvent Solidification Process
Application: 13/099,926 →
Publication: US US20110268806A1
(Indol-3-Yl) Heterocycle Derivatives as Agonists of the Cannabinoid CB1 Receptor
Patent: 7,700,634 →
Application: 10/590,674 →
Publication: US US20070142446A1
X-Ray Visible Drug Delivery Device
Patent: 8,722,037 →
Application: 10/592,725 →
Publication: US US20080112892A1
Progesterone Receptor Modulators
Patent: 7,691,836 →
Application: 10/594,103 →
Publication: US US20070203105A1
Drug Delivery System Based on Polyethylene Vinylacetate Copolymers
Patent: 8,481,079 →
Application: 10/594,104 →
Publication: US US20070141102A1
Novel Androgens
Patent: 7,812,036 →
Application: 11/587,192 →
Publication: US US20070225352A1
Novel Androgens
Application: 12/887,607 →
Publication: US US20110009428A1
Pharmaceutical composition comprising a salt of mirtazapine
Application: 11/547,152 →
Publication: US US20070111993A1
Optimized Deployment of Parts in a Supply Chain Network
Patent: 7,685,015 →
Application: 12/031,975 →
Publication: US US20080147490A1
Process for the Preparation 2-Substituted-Derivatives of Estrone and Estradiol
Patent: 7,910,756 →
Application: 11/659,147 →
Publication: US US20090012319A1
Process for the Preparation of Estrone and/or Estradiol-Derivates
Patent: 8,273,908 →
Application: 11/661,156 →
Publication: US US20070299268A1
15 Beta-Substituted Steroids Having Selective Estrogenic Activity
Patent: 7,838,516 →
Application: 11/662,166 →
Publication: US US20070254860A1
Pulmonary administration of an antithrombotic compound
Application: 11/664,803 →
Publication: US US20090227528A1
S-Mirtazapine for the Treatment of Hot Flush
Application: 12/828,720 →
Publication: US US20100267694A1
Drug Combination Comprising A Selective Serotonin Reuptake Inhibitor And A Glucocorticoid Receptor Antagonist For The Treatment Of Depression
Application: 11/791,242 →
Publication: US US20080255074A1
Antithrombotic Dual Inhibitors Comprising a Biotin Residue
Patent: 8,168,595 →
Application: 11/722,444 →
Publication: US US20100004186A1
Applicator for Inserting an Implant
Patent: 8,888,745 →
Application: 11/795,796 →
Publication: US US20080221510A1
Conjugates of a Polypeptide and a Pentasaccharide
Patent: 8,106,007 →
Application: 11/815,131 →
Publication: US US20080139459A1
Conjugates of a Polypeptide and an Oligosaccharide
Application: 13/227,910 →
Publication: US US20120039843A1
Glycine Reuptake Inhibitors for Treatment of Drug Dependence
Application: 11/813,894 →
Publication: US US20080051456A1
Applicator for Inserting an Implant
Patent: 9,757,552 →
Application: 11/795,805 →
Publication: US US20100298807A1
Non Steroidal Glucocorticoid Receptor Modulators
Patent: 8,133,885 →
Application: 11/816,113 →
Publication: US US20090062262A1
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]-Oxepino[4,5-C]Pyrrole
Patent: 7,956,202 →
Application: 12/632,513 →
Publication: US US20100152461A1
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]Oxepino[4,5-C]Pyrrole
Patent: 7,872,147 →
Application: 11/399,142 →
Publication: US US20060229352A1
2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists
Patent: 7,807,686 →
Application: 11/908,221 →
Publication: US US20080214553A1
1-Benzylindole-2-Carboxamide Derivatives
Patent: 7,671,080 →
Application: 11/908,640 →
Publication: US US20080280923A1
Dihydropyridine Derivatives
Patent: 7,994,189 →
Application: 11/912,719 →
Publication: US US20090215773A1
4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility
Patent: 8,022,218 →
Application: 11/912,736 →
Publication: US US20080275042A1
4-Phenyl-5-Oxo-1,4,5,6,7,8,- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
Patent: 8,034,945 →
Application: 11/912,746 →
Publication: US US20080300270A1
4-Phenyl-5-Oxo-1,4,5,6,7,8- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
Patent: 8,017,782 →
Application: 11/912,756 →
Publication: US US20080262033A1
Regimens for Controlled Drug Delivery Devices for Contraception
Application: 11/917,485 →
Publication: US US20080206310A1
Regimens for Oral Monophasic Contraceptives
Application: 11/917,492 →
Publication: US US20080207571A1
Method of Treatment of Hormone Depletion Induced Vasomotor Symptoms
Application: 11/917,456 →
Publication: US US20090306046A1
Synergistic Combination for the Treatment of Pain (Cannabinoid Receptor Agonist and Opioid Receptor Agonist)
Application: 11/995,243 →
Publication: US US20090029984A1
Indole Derivatives
Patent: 7,763,732 →
Application: 11/506,579 →
Publication: US US20070082931A1
4-Phenyl-6-Substituted-Pyrimidine-2-Carbonitrile Derivatives
Patent: 7,326,715 →
Application: 11/524,841 →
Publication: US US20070111992A1
Non-Steroidal Compounds Useful as Glucocorticoid Receptor Modulators
Patent: 8,575,152 →
Application: 12/065,241 →
Publication: US US20080188459A1
9-Azabicyclo[3.3.1]Nonane Derivatives
Patent: 7,868,017 →
Application: 11/541,273 →
Publication: US US20070112019A1
2-(Benzimidazol-1-Yl)-Acetamide Bisaryl Derivatives
Patent: 7,482,469 →
Application: 11/593,741 →
Publication: US US20070112034A1
2-(Benzimidazol-1-Yl)-N-(4-Phenylthiazol-2-Yl) Acetamide Derivatives
Application: 12/643,363 →
Publication: US US20100099722A1
2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
Application: 11/593,742 →
Publication: US US20070105920A1
Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label
Patent: 8,183,228 →
Application: 12/083,212 →
Publication: US US20100029582A1
Antithrombotic Compound
Application: 12/083,213 →
Publication: US US20090111769A1
Isoquinoline Derivatives
Patent: 7,618,985 →
Application: 11/633,973 →
Publication: US US20070135479A1
8-Azabicyclo[3.2.1]Octane Derivatives
Patent: 7,605,170 →
Application: 11/607,574 →
Publication: US US20070185156A1
Compounds with Medicinal Effects Due to Interaction with the Glucocorticoid Receptor
Patent: 7,960,365 →
Application: 11/641,524 →
Publication: US US20070149577A1
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Patent: 7,687,515 →
Application: 11/653,600 →
Publication: US US20070179138A1
Aminoisoquinoline Thrombin Inhibitor with Improved Bioavailability
Patent: 8,299,091 →
Application: 12/376,529 →
Publication: US US20100305153A1
Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides
Application: 12/087,849 →
Publication: US US20090093016A1
Kit for and Method of Assembling an Applicator for Inserting an Implant
Application: 12/174,644 →
Publication: US US20090012463A1
Method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
Application: 11/714,301 →
Publication: US US20070208002A1
Mirtazapine for the treatment of neuropathic pain
Application: 11/804,300 →
Publication: US US20070270413A1
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Patent: 7,750,167 →
Application: 11/773,084 →
Publication: US US20080009619A1
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Patent: 8,227,623 →
Application: 12/785,805 →
Publication: US US20100234618A1
Stereoselective Synthesis of (S)-1-Methyl-3-Phenylpiperazine
Application: 12/304,557 →
Publication: US US20100036126A1
Heterocyclic Derivatives
Patent: 7,820,707 →
Application: 11/771,198 →
Publication: US US20080255086A1
6-Substituted Isoquinoline Derivatives
Patent: 7,893,088 →
Application: 11/839,703 →
Publication: US US20080045566A1
2-(1-Oxo-1H-Isoquinolin-2-Yl)Acetamide Derivatives
Patent: 7,906,504 →
Application: 11/852,737 →
Publication: US US20080064678A1
Quinazolinone and Isoquinolinone Acetamide Derivatives
Patent: 7,820,649 →
Application: 11/852,762 →
Publication: US US20080090802A1
New Progesterone Receptor Modulators
Patent: 7,989,442 →
Application: 11/861,427 →
Publication: US US20080090804A1
Purines as Pkc-Theta Inhibitors
Application: 12/445,862 →
Publication: US US20110046131A1
Ih Channel Inhibitors for the Promotion of Wakefulness
Application: 12/446,532 →
Publication: US US20110092486A1
V3 Antagonists for the Treatment or Prevention of Chronic Pain
Application: 12/518,940 →
Publication: US US20100179176A1
Oral Contraceptive Spray
Application: 12/518,732 →
Publication: US US20100105641A1
Indole Derivatives
Patent: 7,655,645 →
Application: 12/031,851 →
Publication: US US20080207598A1
Accurate Method to Assess Disease Severity in Clinical Trials Concerning Psychopathology
Application: 12/056,741 →
Publication: US US20090024003A1
Method for the Preparation of an Enantiomerically Pure Benzazepine
Patent: 7,994,314 →
Application: 12/098,677 →
Publication: US US20080255349A1
Method for the Preparation of an Enantiomer of a Tetracyclic Benzazepine
Application: 12/098,662 →
Publication: US US20080255348A1
New Progesterone Receptor Modulators
Patent: 8,063,037 →
Application: 12/115,983 →
Publication: US US20090054400A1
Drug Delivery System
Patent: 8,741,329 →
Application: 12/234,261 →
Publication: US US20090081278A1
Intrauterine Deposit
Patent: 8,291,910 →
Application: 12/740,837 →
Publication: US US20110017219A1
Selective Enzymatic Amidation of C-Terminal Esters or Acids of Peptides
Patent: 8,124,372 →
Application: 12/145,100 →
Publication: US US20090053760A1
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Patent: 7,932,251 →
Application: 12/173,623 →
Publication: US US20090099172A1
5- Phenyl-Isoxazole-3-Carboxamide Derivatives as TRPV1 Modulators
Patent: 8,211,927 →
Application: 12/671,113 →
Publication: US US20110065764A1
N-Benzyl,N'-Arylcarbonylpiperazine Derivatives
Patent: 8,314,091 →
Application: 12/194,146 →
Publication: US US20090264416A1
Tsh Receptor Antagonizing Tetrahydroquinoline Compounds
Patent: 9,174,940 →
Application: 12/675,012 →
Publication: US US20110172267A1
Tricyclic Heterocyclic Derivatives
Application: 12/678,184 →
Publication: US US20100210680A1
Method of Hormone Suppression in Humans
Application: 12/740,716 →
Publication: US US20110118353A1
Substituted Thieno[2,3-D]Pyrimidines as Ampa Modulators
Patent: 8,129,397 →
Application: 12/269,306 →
Publication: US US20090131455A1
Mineralocorticoid Receptor Antagonists
Application: 12/593,746 →
Publication: US US20100120736A1
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Patent: 7,964,739 →
Application: 12/341,281 →
Publication: US US20090227803A1
Dihydro)Pyrrolo[2,1-A]Isoquinolines
Patent: 8,394,789 →
Application: 12/866,468 →
Publication: US US20110039832A1
Purification of Protein Hydrolysate and the Result and Products
Application: 12/988,180 →
Publication: US US20110036133A1
Preparation of a Pharmaceutical Composition for Increasing Bone Mineral Density
Application: 12/407,404 →
Publication: US US20100075893A1
PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
Application: 12/936,604 →
Publication: US US20110218189A1
Hexafluoroisopropanol Derivatives
Patent: 8,357,679 →
Application: 12/465,134 →
Publication: US US20100029621A1
Indane Derivatives as Ampa Receptor Modulators
Patent: 8,536,214 →
Application: 12/996,183 →
Publication: US US20110092539A1
1-(4-Ureidobenzoyl)Piperazine Derivatives
Patent: 8,759,352 →
Application: 13/060,730 →
Publication: US US20120015958A1
1-(Biphenyl-4-Ylmethyl)Imidazolidine-2,4-Dione
Patent: 7,960,560 →
Application: 12/628,523 →
Publication: US US20100144723A1
(Pyrrolidin-2-Yl)Phenyl Derivatives
Patent: 8,188,123 →
Application: 12/611,468 →
Publication: US US20100113493A1
1-(4-(Pyridin-2-Yl)Benzyl)Imidazolidine-2,4-Dione Derivatives
Patent: 8,143,246 →
Application: 12/628,538 →
Publication: US US20100144724A1
Tetrahydronaphthalen-2-Ol Derivatives
Patent: 8,063,102 →
Application: 12/721,842 →
Publication: US US20100240748A1
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Patent: 8,026,236 →
Application: 12/686,692 →
Publication: US US20100184761A1
Isoxazole-5-Carboxamide Derivatives
Application: 13/256,561 →
Publication: US US20120095002A1
Isoxazole-5-Carboxamide Derivatives
Application: 13/256,553 →
Publication: US US20120071481A1
Tricyclic Heterocyclic Derivatives
Patent: 8,729,274 →
Application: 13/255,630 →
Publication: US US20120232122A1
Intrauterine System
Patent: 8,568,374 →
Application: 12/770,105 →
Publication: US US20100280464A1
(Dihydro)Imidazoiso[5,1-A]Quinolines
Patent: 8,071,587 →
Application: 12/786,996 →
Publication: US US20100324021A1
Apparatus and Method for Preserving Mucosa
Application: 12/841,864 →
Publication: US US20110020177A1
Substituted 16,17-Annellated Steriod Compounds for Use in Womens Healthcare
Patent: 8,367,648 →
Application: 12/795,970 →
Publication: US US20100331292A1
Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines
Patent: 8,431,564 →
Application: 12/844,007 →
Publication: US US20110028450A1
Dihydrobenzoindazoles
Patent: 8,071,589 →
Application: 12/845,813 →
Publication: US US20110028451A1
Treatment of bipolar disorders and associated symptoms
Application: 11/247,342 →
Publication: US US20060084692A1
Treatment of Bipolar Disorders and Associated Symptoms
Application: 12/405,689 →
Publication: US US20090176855A1
Crystal Form of Asenapine Maleate
Patent: 7,741,358 →
Application: 11/399,204 →
Publication: US US20070027134A1
Antibodies to Human Programmed Death Receptor Pd-1
Patent: 8,354,509 →
Application: 12/663,950 →
Publication: US US20100266617A1
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]-Oxepino[4,5-C]Pyrrole
Patent: 8,426,610 →
Application: 13/098,688 →
Publication: US US20110207942A1
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Application: 13/049,139 →
Publication: US US20110166363A1
Timer
Patent: 472,162 →
Application: 29/160,362 →
Applicator for Inserting an Implant
Patent: 551,759 →
Application: 29/242,104 →
Pill Case for Holding a Blister Pack
Patent: 601,337 →
Application: 29/304,081 →
Slide Case Tablet Dispenser
Patent: 645,244 →
Application: 29/342,900 →
Slide Case Tablet Dispenser
Patent: 645,658 →
Application: 29/342,896 →
Slide Case Tablet Dispenser
Patent: 647,295 →
Application: 29/342,894 →
Timer
Patent: 460,004 →
Application: 29/138,849 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Mar 7, 2013
From: MSD OSS B.V.
To: ORGANON BIOSCIENCES NEDERLAND B.V.
Reel/Frame 029939/0001 →
Merger Mar 8, 2013
From: ORGANON BIOSCIENCES NEDERLAND B.V.
To: MERCK SHARP & DOHME B.V.
Reel/Frame 029940/0296 →
Assignment of Assignor's Interest Jan 29, 2014
From: MERCK SHARP & DOHME BV; ORGANON LIMITED
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 032077/0550 →